Leukaemia

Source: au.rd.yahoo.com --- 3 days ago
All Saints viewers interested in getting more information can contact The Leukaemia Foundation on 1800 620 420 or click below for their website. ...

Source: au.rd.yahoo.com --- 30 days ago
Researchers from Brisbane's Princess Alexandra Hospital (PAH) and the University of Queensland say they have made two breakthroughs that could lead to a cure for a common type of Leukaemia within five years. ...

Source: news.bbc.co.uk --- 4 days ago
A bone marrow donor for a six-year-old boy with Leukaemia is found but doctors face a race against time. ...

Source: news.bbc.co.uk --- 1 day ago
Identical twins look forward to life at secondary school after both surviving Leukaemia. ...

Source: www.moreover.com --- 2 days ago
Research recently published in Nature Genetics proves for the first time that chronic lymphocytic Leukaemia (CLL) has a genetic basis. ...

Source: www.ncbi.nlm.nih.gov --- 2 days ago
Related Articles Significantly shorter telomeres in T-cells of patients with ZAP-70(+)/CD38(+) chronic lymphocytic Leukaemia. Br J Haematol. 2008 Aug 28; Authors: Röth A, de Beer D, Nückel H, Sellmann L, Dührsen U, Dürig J, Baerlocher GM In contrast to other B-cell neoplasias, chronic lymphocytic Leukaemia (CLL) is characterized by increased non-leukaemic T-cells. In order to assess their replicative history, telomere length was analyzed in subsets of leucocytes from CLL patients. Naive and memory T-cells from ZAP-70(+)/CD38(+) patients exhibited significantly shorter average telomere lengths than ZAP-70(-)/CD38(-) patients. Compared to the age-related percentiles of telomere length values from healthy individuals practically all values of the naive and memory T-cells from the ZAP-70(+)/CD38(+) CLL patients fell below the 50th percentile. This indicated an extensive expansion and a role for T-cells in ZAP-70(+)/CD38(+) CLL patients. PMID: 18759763 [PubMed - as supplied by publisher] ...

Source: timesofindia.indiatimes.com --- 24 days ago
Australian scientists said Monday they had mapped a blood cell structure which could hold the key to improved drug treatments for diseases such as Leukaemia, asthma and rheumatoid arthritis. ...

Source: www.moreover.com --- 15 days ago
Adrian Sudbury received a bone marrow transplant that gave him valuable time with friends and family Photo: AP Huddersfield Daily Examiner reporter Adrian Sudbury, 27, passed away with his family beside him at their home in Nottinghamshire, the paper ...

Source: www.moreover.com --- 25 days ago
AUSTRALIAN scientists are hoping to cure Leukaemia, asthma and rheumatoid arthritis after their breakthrough discovery of how to stop killer blood cells growing The team has unlocked the secrets behind the protein which controls the way the blood ...

Source: www.moreover.com --- 4 days ago
TEAMS of doctors today said they had uncovered genetic flaws that separately boost the risk of a common form of Leukaemia and bowel disease in children and may also influence obesity and fertility. ...

Source: www.moreover.com --- 4 days ago
TEAMS of doctors today said they had uncovered genetic flaws that separately boost the risk of a common form of Leukaemia and bowel disease in children and may also influence obesity and fertility. ...

Source: www.moreover.com --- 23 days ago
SYDNEY: Australian scientists said yesterday they had mapped a blood cell structure which could hold the key to improved drug treatments for diseases such as Leukaemia, asthma and rheumatoid arthritis. ...

Source: www.moreover.com --- 4 days ago
Genetic susceptibility to most common form of Leukaemia discovered Science In Focus We take a look at the highs and lows of the past five decades of the National Aeronautics and Space Administration (Nasa). Full Story Green revolution A genetic ...

Source: www.ncbi.nlm.nih.gov --- 2 days ago
Related Articles Bone-marrow relapse in paediatric acute lymphoblastic Leukaemia. Lancet Oncol. 2008 Sep;9(9):873-83 Authors: Bailey LC, Lange BJ, Rheingold SR, Bunin NJ Marrow relapse is the major obstacle to cure for 10-15% of young patients with acute lymphoblastic Leukaemia (ALL). Recent investigations into the biology of minimal residual disease indicate that many early relapses derive from residual cells present at first diagnosis, but some late relapses might represent new mutations in leukaemic cells not eliminated by conventional therapy. Treatment of marrow relapse involves higher doses and more intensive schedules of the drugs used for initial therapy with or without haemopoietic stem cell transplantation. In most reports, transplantation is better than continuation chemotherapy in early marrow relapse, but its role in later relapse is less clear. Current therapy cures 10% of patients with early marrow relapses and 50% of those with late relapses, but outcomes have changed little in the past two decades. Understanding the molecular biology of ALL underlies development of improved risk stratification and new therapies. Although better drugs are needed, introduction of new agents into clinical trials in paediatric disease has been difficult. Innovative trial designs and use of valid surrogate endpoints may expedite this process. PMID: 18760243 [PubMed - in process] ...

Source: www.moreover.com --- 4 days ago
Teams of doctors said they had uncovered genetic flaws that separately boost the risk of a common form of Leukaemia and bowel disease in children and may also influence obesity and fertility. ...

Source: www.moreover.com --- 4 days ago
Teams of doctors said they had uncovered genetic flaws that separately boost the risk of a common form of Leukaemia and bowel disease in children and may also influence obesity and fertility. ...

Source: news.ninemsn.com.au --- 24 days ago
11 Aug 2008 ...

Source: www.dailymail.co.uk --- 2 days ago
Identical twins Katie and Chelsea Young started secondary school today after both beating Leukaemia. ...